Actively Recruiting
Non-invasive Monitoring of Miscarriage
Led by Chinese University of Hong Kong · Updated on 2024-11-12
150
Participants Needed
1
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
cfDNA is extremely useful to ascertain chromosomal causes of miscarriages at the point of miscarriage diagnosis by a simple blood test. This study aims to determine the level of cell-free DNA (cfDNA) in early pregnancy and compare the results with those of product of conception (POC) testing, in concordance with standard karyotyping.
CONDITIONS
Official Title
Non-invasive Monitoring of Miscarriage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-45 years.
- Women who attend the early pregnancy loss clinic or patients who receive assisted reproductive technologies (ART).
- Their partner, the biological father of the pregnancy.
You will not qualify if you...
- History of psychological or psychiatric problems.
- Patient refusal to participate.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
P
PUI WAH JACQUELINE CHUNG
CONTACT
Y
Yee Lee Elaine NG
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here